Rivkees Scott A
Yale Pediatric Thyroid Center, Department of Pediatrics, Yale University School of Medicine, New Haven, CT 06520, USA.
J Pediatr Endocrinol Metab. 2006 Sep;19(9):1095-111. doi: 10.1515/jpem.2006.19.9.1095.
Graves' disease is the most common form of hyperthyroidism in childhood. Current treatment options include antithyroid medications, surgery, and radioactive iodine. Medical therapy is generally associated with long-term remission rates of less than 25% and a small risk of serious adverse reactions that include hepatic failure and bone marrow suppression. Total thyroidectomy is associated with very high cure rates and a small risk of hypoparathyroidism and recurrent laryngeal nerve damage. When radioactive iodine is used at appropriate doses, there is a very high cure rate without increased risks of thyroid cancer or genetic damage. Clinicians caring for the child or adolescent with Graves' disease are thus faced with using medications with potential short-term and long-term toxicity, for a condition in which spontaneous remission occurs in the minority of pediatric patients. Definitive therapy in the form of surgery or radioactive iodine is necessary and unavoidable for the majority of pediatric patients with Graves' disease.
格雷夫斯病是儿童期最常见的甲状腺功能亢进症形式。目前的治疗选择包括抗甲状腺药物、手术和放射性碘。药物治疗通常与低于25%的长期缓解率相关,并且存在包括肝衰竭和骨髓抑制在内的严重不良反应的小风险。全甲状腺切除术与非常高的治愈率以及甲状旁腺功能减退和喉返神经损伤的小风险相关。当以适当剂量使用放射性碘时,有非常高的治愈率,且不会增加甲状腺癌或遗传损伤的风险。因此,照顾患有格雷夫斯病的儿童或青少年的临床医生面临着为少数儿科患者会自发缓解的疾病使用具有潜在短期和长期毒性的药物的情况。对于大多数患有格雷夫斯病的儿科患者来说,手术或放射性碘形式的确定性治疗是必要且不可避免的。